Camber Pharma Launches Generic Evista



Piscataway, NJ, September 26, 2014— Camber Pharmaceuticals announced Thursday that it has launched Raloxifene Hydrochloride, USP 60 mg tablets. The drug is the generic version of Evista® (raloxifene hydrochloride) tablets from Eli Lilly and Company. Raloxifene is available in 30 and 100 count bottles.

“Raloxifene is an important product addition in Camber’s portfolio, one of many we have planned in the coming months” said Kon Ostaficiuk, president of Camber. “Our continued growth as a leading generic supplier is a testament to our strong API manufacturing and the integrity of our supply chain.”

Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.

Related Videos -
Whole psilocybin mushroom in a clear medication capsule | Image credit: Zim -
Patient suffering from atopic dermatitis -- Image credit: Nikkikii |
Image credit: Fabio Balbi |
Image credit: Melita -
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская |
cropped view of man performing chest compression on dummy during cpr training class - Image credit: LIGHTFIELD STUDIOS |
Medicine law concept. Judges gavel with pills | Image Credit: Iren Moroz -
Image credit: New Africa |
© 2024 MJH Life Sciences

All rights reserved.